Thomas Jefferson University

Pramila Anne

TitleProfessor
InstitutionThomas Jefferson University
DepartmentRadiation Oncology
Address111 S. 11th Street
Philadelphia PA 19107
Phone215-955-6702
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Majeed A, Alaparthi S, Halegoua-DeMarzio D, Eberle-Singh J, Jiang W, Anne PR, Shah AP, Bowne WB, Lin D. Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. World J Oncol. 2024 Jun; 15(3):511-520. PMID: 38751709.
      Citations:    
    2. Lamm R, Woodward SG, Varshney K, Lyons W, Anne PR, George BJ, Willis AI. A comparison of timely completion of hypofractionated and traditional adjuvant radiation therapy in early-stage breast cancer: Evidence of impact on reducing racial and socioeconomic disparities. Surgery. 2022 Apr 27. PMID: 35489980.
      Citations:    
    3. Minor DR, Kim KB, Tong RT, Wu MC, Kashani-Sabet M, Orloff M, Eschelman DJ, Gonsalves CF, Adamo RD, Anne PR, Luke JJ, Char D, Sato T. A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma. Cancer Biother Radiopharm. 2022 Feb; 37(1):11-16. PMID: 35021863.
      Citations:    
    4. Taylor JM, Song A, Nowak K, Dan T, Simone B, Harrison A, Doyle L, Lockamy V, Anne P, Simone N. Dosimetric Comparisons of Simulation Techniques for Left-Sided Breast Cancer in the COVID-19 Era: Techniques to Reduce Viral Transmission and Respect the Therapeutic Ratio. Cureus. 2021 Feb 15; 13(2):e13354. PMID: 33747655.
      Citations:    
    5. Song A, Manukian G, Taylor A, Anne PR, Simone NL. Concerns for activated breathing control (ABC) with breast cancer in the era of COVID-19: Maximizing infection control while minimizing heart dose. Adv Radiat Oncol. 2020 Apr 01. PMID: 32292838.
      Citations:    
    6. Arthur DW, Winter KA, Kuerer HM, Haffty B, Cuttino L, Todor DA, Anne PR, Anderson P, Woodward WA, McCormick B, Cheston S, Sahijdak WM, Canaday D, Brown DR, Currey A, Fisher CM, Jagsi R, Moughan J, White JR. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial. JAMA Oncol. 2019 Nov 21. PMID: 31750868.
      Citations:    
    7. Gilani MA, Williams NL, Giordano C, Rosenblum N, Shi W, Anne P, Schilder RJ. Brain Metastases in Patients with Gynecologic Cancers: A Single Institution Experience and Review of the Literature. Open J Obstet Gynecol. 2016 Aug; 6(9):544-552. PMID: 31552146.
      Citations:    
    8. Ahn PH, Machtay M, Anne PR, Cognetti D, Keane WM, Wuthrick E, Dicker AP, Axelrod RS. Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer. Am J Clin Oncol. 2016 Jul 07. PMID: 27391356.
      Citations:    
    9. Eldredge-Hindy H, Ohri N, Anne PR, Eschelman D, Gonsalves C, Intenzo C, Bar-Ad V, Dicker A, Doyle L, Li J, Sato T. Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography. Am J Clin Oncol. 2016 Apr; 39(2):189-95. PMID: 24441583.
      Citations:    
    10. Kleinberg LR, Catalano PJ, Forastiere AA, Keller SM, Mitchel EP, Anne PR, Benson AB. Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):738-46. PMID: 26972646.
      Citations:    
    11. Hong TS, Moughan J, Garofalo MC, Bendell J, Berger AC, Oldenburg NB, Anne PR, Perera F, Lee RJ, Jabbour SK, Nowlan A, DeNittis A, Crane C. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2015 Sep 1; 93(1):29-36. PMID: 26163334.
      Citations:    
    12. Eldredge-Hindy HB, Duffy D, Yamoah K, Simone NL, Skowronski J, Dicker AP, Anne PR. Modeled risk of ischemic heart disease following left breast irradiation with deep inspiration breath hold. Pract Radiat Oncol. 2015 May-Jun; 5(3):162-8. PMID: 25957186.
      Citations:    
    13. Eldredge-Hindy H, Lockamy V, Crawford A, Nettleton V, Werner-Wasik M, Siglin J, Simone NL, Sidhu K, Anne PR. Active Breathing Coordinator reduces radiation dose to the heart and preserves local control in patients with left breast cancer: Report of a prospective trial. Pract Radiat Oncol. 2015 Jan-Feb; 5(1):4-10. PMID: 25567159.
      Citations:    
    14. Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2015 Jan 1; 91(1):116-23. PMID: 25446610.
      Citations:    
    15. Eldredge-Hindy HB, Eastwick G, Anne PR, Rosenblum NG, Schilder RJ, Chalian R, Zibelli AM, Kim CH, Den R. Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer. J Contemp Brachytherapy. 2014 Oct; 6(3):262-70. PMID: 25337127.
      Citations:    
    16. Shen X, Anne PR, Keith SW, Wojcieszynski A, Mishra MV, Bar-Ad V, Showalter TN. Radiation Therapy Use and Outcomes Among Older Women With ER-Positive and ER-Negative Stage I Breast Cancer. Am J Clin Oncol. 2014 Jun; 37(3):241-7. PMID: 23241502.
      Citations:    
    17. Mishra MV, Champ CE, Keith SW, Showalter TN, Anne PR, Lawrence YR, Bar-Ad V. Conditional survival probabilities for patients with resected pancreatic adenocarcinoma. Am J Clin Oncol. 2014 Apr; 37(2):107-11. PMID: 23111364.
      Citations:    
    18. Zaorsky NG, Malatesta TM, Showalter TN, Den RB, Shi W, Anne PR, Werner-Wasik M, Dicker AP, Bar-Ad V. Impact of a radiation oncology elective on the careers of young physicians: update on a prospective cohort study. Int J Radiat Oncol Biol Phys. 2013 Jun 1; 86(2):214-5. PMID: 23498775.
      Citations:    
    19. Siglin J, Champ CE, Vakhnenko Y, Anne PR, Simone NL. Radiation therapy for locally recurrent breast cancer. Int J Breast Cancer. 2012; 2012:571946. PMID: 23091733.
      Citations:    
    20. Rich TA, Winter K, Safran H, Hoffman JP, Erickson B, Anne PR, Myerson RJ, Cline-Burkhardt VJ, Perez K, Willett C. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer. Onco Targets Ther. 2012; 5:161-70. PMID: 22977306.
      Citations:    
    21. Kubicek GJ, Axelrod RS, Machtay M, Ahn PH, Anne PR, Fogh S, Cognetti D, Myers TJ, Curran WJ, Dicker AP. Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):1192-7. PMID: 22245208.
      Citations:    
    22. Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):1367-75. PMID: 21775070.
      Citations:    
    23. Schwartz GK, Winter K, Minsky BD, Crane C, Thomson PJ, Anne P, Gross H, Willett C, Kelsen D. Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114). J Clin Oncol. 2009 Apr 20; 27(12):1956-62. PMID: 19273696.
      Citations:    
    24. Showalter TN, Nawaz AO, Fellin FM, Anne PR, Rosato EL, Dicker AP. Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: a case report. J Med Case Rep. 2008; 2:76. PMID: 18328104.
      Citations:    
    25. Poltinnikov IM, Rudoler SB, Tymofyeyev Y, Kennedy J, Anne PR, Curran WJ. Impact of Her-2 Neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer: an exploratory analysis. Am J Clin Oncol. 2006 Feb; 29(1):71-9. PMID: 16462507.
      Citations:    
    26. Charara M, Edmonston TB, Burkholder S, Walters R, Anne P, Mitchell E, Fry R, Boman B, Rose D, Fishel R, Curran W, Palazzo J. Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. Anticancer Res. 2004 Sep-Oct; 24(5B):3161-7. PMID: 15510606.
      Citations:    
    27. Bednarz G, Michalski D, Anne PR, Valicenti RK. Inverse treatment planning using volume-based objective functions. Phys Med Biol. 2004 Jun 21; 49(12):2503-14. PMID: 15272670.
      Citations:    
    28. Heron DE, Stein DE, Eschelman DJ, Topham AK, Waterman FM, Rosato EL, Alden M, Anne PR. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Am J Clin Oncol. 2003 Aug; 26(4):422-8. PMID: 12902899.
      Citations:    
    29. Bednarz G, Michalski D, Houser C, Huq MS, Xiao Y, Anne PR, Galvin JM. The use of mixed-integer programming for inverse treatment planning with pre-defined field segments. Phys Med Biol. 2002 Jul 7; 47(13):2235-45. PMID: 12164584.
      Citations:    
    Anne's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (75)
    Explore
    _
    Co-Authors (40)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _